Language selection

Search

Patent 1166640 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1166640
(21) Application Number: 389924
(54) English Title: 2-OXOAZETIDINE DERIVATIVES AND PRODUCTION THEREOF
(54) French Title: DERIVES DE 2-OXOAZETIDINE ET PREPARATION
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/306.05
  • 260/335.3
(51) International Patent Classification (IPC):
  • C07D 403/04 (2006.01)
  • C07C 205/42 (2006.01)
  • C07D 205/08 (2006.01)
  • C07D 205/085 (2006.01)
  • C07D 499/00 (2006.01)
(72) Inventors :
  • NUMATA, MITSUO (Japan)
  • YAMAOKA, MASAYOSHI (Japan)
  • NISHIMURA, TATSUO (Japan)
  • MATSUMOTO, NORICHIKA (Japan)
(73) Owners :
  • TAKEDA CHEMICAL INDUSTRIES, LTD. (Japan)
(71) Applicants :
(74) Agent: FETHERSTONHAUGH & CO.
(74) Associate agent:
(45) Issued: 1984-05-01
(22) Filed Date: 1981-11-12
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
80/00281 Japan 1980-11-13

Abstracts

English Abstract



ABSTRACT
2-Oxoazetidine derivatives represented by the formula;
<IMG > (I)

wherein R1 stands for phthalimido group, benzyloxycarbonylamino group, a
halogen or an alkyl group which may have hydroxyl group, R2 stands for hydrogen,an alkyl group, an alkylthio group or an arylthio group, and R3 and R4
independently stand for an acyl group or cyano group, and a method of preparing
them, which is shown by the following reaction scheme;
Image + Image (I)
(II) (III)
wherein R5 stands for a carboxyl-protective group, and R1, R2, R3 and R4 are of
the same meanings as defined above. This compound (I) can be utilized as an
intermetiate for carba-2-penem compounds which have excellent anti-bacterial
activity and .beta.-lactamase inhibitory activity.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE .
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A process of preparing 2-oxoazetidine derivatives represented by
the formula;

Image


wherein Rl stands for phthalimido group, benzyloxycarbonylamino group, a halogen
or an alkyl group which may have hydroxyl group, R2 stands for hydrogen, an
alkyl group, an alkylthio group or an arylthio group, and R3 and R4 independent-
ly stand for an acyl group or cyano group, which comprises subjecting a compound
represented by the formula;
Image


wherein R1 has the same meaning as defined above, R5 stands for a carboxyl-
protecting group, to react with a compound represented by the formula;
Image

wherein R2 , R3 and R4 have the same meanings as defined above, in the presence
of an alcohol and a base.

44


2. A compound represented by the formula;

Image

wherein R1 stands for phthalimido group, benzyloxycarbonylamino group, a halogen
or an alkyl group which may have hydroxyl group, R2 stands for hydrogen, an alkyl
group, an alkylthio group or an arylthio group, and R3 and R4 independently
stand for an acyl group or cyano group whenever prepared by a process according
to claim 1 or by an obvious chemical equivalent thereof.
3. A process of preparing 2-oxoazetidine derivatives represented by the
formula;

Image
wherein R1 stands for phthalimido group, benzyloxycarbonylamino or an alkyl
group which may have hydroxyl group, R2 stands for hydrogen, an alkyl group, an
alkylthio group or an arylthio group and R3 and R4 independently stand for an
acyl group or cyano group which comprises subjecting a compound represented by
the formula;

Image
wherein R1 has the same meaning as defined above, R5 stands for a carboxyl-
protecting group, to react with a compound represented by the formula;




Image

wherein R2, R3 and R4 have the same meanings as defined above, in the presence
of an alcohol and a base.
4. A compound represented by the formula;
Image
wherein R1 stands for phthalimido group, benzyloxycarbonylamino or an alkyl
group which may have hydroxyl group, R2 stands for hydrogen, an alkyl group,
an alkylthio group or an arylthio group and R3 and R4 independently stand for
an acyl group or cyano group whenever prepared by a process according to claim
3 or by an obvious chemical equivalent thereof.
5. A process of preparing 2-oxoazetidine derivatives represented by
the formula;

46



Image

wherein R1 stands for phthalimido group, benzyloxycarbonylamino group, a halogen
or an alkyl group which may have hydroxyl group, R2 stands for hydrogen, an
alkyl group, an alkylthio group or an arylthio group and R3 and R4 independently
stand for an acyl group which comprises subjecting a compound represented by
the formula;

Image

wherein R1 has the same meaning as defined above, R5 stands for a carboxyl-
protecting group, to react with a compound represented by the formula;
Image

wherein R2, R3 and R4 have the same meanings as defined above, in the presence
of an alcohol and a base.
6. A compound represented by the formula;

47



Image

wherein R1 stands for phthalimido group, benzyloxycarbonylamino group, a halogen
or an alkyl group which may have hydroxyl group, R2 stands for hydrogen, an
alkyl group, an alkylthio group or an arylthio group and R3 and R4 independently
stand for an acyl group whenever prepared by a process according to claim 5 or
by an obvious chemical equivalent thereof.
7. A process of preparing 2-oxoazetidine derivatives represented by
the formula;

Image

wherein R1 stands for phthalimido group, benzyloxycarbonylamino group, a halogen
or an alkyl group which may have hydroxyl group, R2 stands for hydrogen, an
alkyl group, an alkylthio group and R3 and R4 independently stand for lower
(C1-4) alkylcarbonyl group, halogenoacetyl, carboxyacetyl, lower (C1-4)
alkoxycarbonylacetyl, arylthioacetyl, lower (C1-4) alkoxycarbonyl, halogeno
lower (C1-4) alkoxycarbonyl or 2-diazo-2-(2,2,2-trichloroethoxycarbonyl)acetyl
which comprises subjecting a compound represented by the formula;

48


Image

wherein R1 has the same meaning as defined above, R5 stands for a
carboxyl-protecting group, to react with a compound represented by
the formula;

Image

wherein R2, R3 and R4 have the same meanings as defined above, in
the presence of an alcohol and a base.
8. A compound represented by the formula;

Image

wherein R1 stands for phthalimido group, benzyloxycarbonylamino
group, a halogen or an alkyl group which may have hydroxylgroup,
R2 stands for hydrogen, an alkyl group, an alkylthio group or an
arylthio group and R3 and R4 independently stand for lower (C1-4)
alkylcarbonyl group, halogenoacetyl, carboxyacetyl, lower (C1-4)
alkoxycarbonylacetyl, arylthioacetyl, lower (C1-4) alkoxycarbonyl,
halogeno lower (C1-4) alkoxycarbonyl or 2-diazo-2-(2,2,2-trichloro-
ethoxycarbonyl) acetyl whenever prepared by a process according to
claim 7 or by an obvious chemical equivalent thereof.
9 A process of preparing 2-oxoazetidine derivatives represented

49


by the formula;

Image
wherein R1 stands for phthalimido group, benzyloxycarbonylamino
group, a halogen or an alkyl group which may have hydroxyl group,
R2 stands for hydrogen, an alkyl group, an alkylthio group or an
arylthio group and R3 and R4 independently stand for a group sel-
ected from the class consisting of acetyl, chloroacetyl, methoxy-
carbonyl, ethoxycarbonyl, t-butoxycarbonyl, phenylthioacetyl and
2-diazo-2-(2,2,2-trichloroethoxycarbonyl)acetyl which comprises
subjecting a compound represented by the formula;
Image
wherein R1 has the same meaning as defined above, R5 stands for a
carboxyl-protecting group, to react with a compound represented by
the formula;
Image
wherein R2, R3 and R4 have the same meanings as defined above, in
the presence of an alcohol and a base.


10. A compound represented by the formula;
Image
wherein R1 stands for phthalimido group, benzyloxycarbonylamino
group, a halogen or an alkyl group which may have hydroxyl group,
R2 stands for hydrogen, an alkyl group, an alkylthio group or an
arylthio group, and R3 and R4 independently stand for a group
selected from the class consisting of acetyl, chloroacetyl, methoxy-
carbonyl, ethoxycarbony;, t-butoxycarbonyl, phenylthioacetyl and
2-diazo-2(2,2,2-trichloroethoxycarbonyl)acetyl whenever prepared
by a process according to claim 9 or by an obvious chemical equiv-
alent thereof.
11. A process for preparing 4-(1-acetyl-1-t-butoxycarbonyl)methyl-
3-phthalimido-2-oxoazetidine which comprises reacting a compound
of the formula;
Image
with methyl-2-(4-chloro-3-phthalimido-2-oxoazetidin-1-yl)-2-oxo-
acetate in the presence of methanolic sodium methylate.
12. The compound 4-(1-acetyl-1-t-butoxycarbonyl)methyl-3-phthal-
imido-2-oxoazetidine whenever prepared by the process according to
claim 11 or by an obvious chemical equivalent thereof.
13. A process for preparing 3-benzyloxycarbonylamino-4-(1-t-

51


butoxycarbonyl-1-acetyl) methyl-2-oxoazetidine which comprises re-
acting methyl-2-(3-benzyloxycarbonylamino-4-chloro-2-oxoazetidin-1-
yl)-2-oxoacetate with t-butyl acetoacetate in the presence of
methanolic lithium methoxide.
14. The compound 3-benzyloxycarbonylamino-4-(1-t-butoxycarbonyl-
1-acetyl)methyl-2-oxoazetidine whenever prepared by the process
according to claim 13 or by an obvious chemical equivalent thereof.
15. A process for preparing 3-benzyloxycarbonylamino-4-(1,1-bis-
acetyl) methyl-2-oxoazetidine which comprises reacting 2-(3-benzyl-
oxycarbonylamino-4-chloro-2-oxoazetidin-1-yl)-2-isopropylidenyl-
acetate with acetylacetone in methanolic sodium methylate.
16. The compound 3-benzyloxycarbonylamino-4-(1,1-bisacetyl)methyl-
2-oxoazetidine whenever prepared by the process according to claim
15 or by an obvious chemical equivalent thereof.
17. A process for preparing 4-[1-t-butoxycarbonyl-3-diazo-2-oxo-
3-(2,2,2-trichloroethoxycarbonyl)propyl]-3-(1-hydroxyisopropyl)-
2-oxoazetidine which comprises reacting 2,2,2-trichloroethyl 4-
t-butyloxycarbonyl-2-diazo-3-oxobutyrate with 2-[4-chloro-3-(1-
hydroxyisopropyl)-2-oxoazetidin-1-yl]-2-oxoacetate in the presence
of methanolic sodium methoxide.
18. The compound 4-[1-t-butoxycarbonyl-3-diazo-2-oxo-3-(2,2,2-
trichloroethoxycarbonyl)propyl]-3-(1-hydroxyisopropyl)-2-oxoazet-
idine whenever prepared by a process according to claim 17 or by
an obvious chemical equivalent thereof.

52


19. A process for preparing 4-(1-t-butoxycarbonyl-1-chloroacetyl)
methyl-3-phthalimido-2-oxoazetidine which comprises reacting
methyl-2-(4-chloro-3-phthalimido-2-oxoazetidin-1-yl)-2-oxoacetate
with a compound of the formula:

53



Image
in the presence of methanolic sodium methylate.

20. The compound 4-(1-t-butoxycarbonyl-1-chloroacetyl)methyl-3-phthal-
imido-2-oxoazetidine whenever prepared by the process according to claim 19 or
by an obvious chemical equivalent thereof.

54

Description

Note: Descriptions are shown in the official language in which they were submitted.


1`6S64~




-. 1
2-Oxoazetidine Derivatives and Production Thereof
This invention relates to novel 2-oxoazetidine deri~a-
tives, i.e., useful intermediates for the synthesis of
carba-2-penem compounds having antibacterial activity or ~-
lactamase inhibitory activity, and production thereof.
Recently a number of carba-2-penem compounds having anti-
biotic activity or ~lactamase inhibitory activity have
aroused much attention as promising antibiotic agents, and
thus development of an economical method for the preparation
of these compounds in an industrial scale has become an
important problem.
Since some penicillins, such as 6-aminopenicilla-nic
acid and penicillin G are now commercially available, if
the economical synthesis of carba-2-penem compounds from
these penicillins could be realized, it can be a solution
lS for the above-mentioned problem. As for a prior art con-
cerned, a report states that a 4-chloro-2-azetidinone com-
pound, prepared from a penicillin, is reacted with an
allylcopper compound to afford an intermediate, 4-allyl-2-
azetidinone compound, which is further subjected to about
ten steps thereby resulting the car~a-2-penem compound
~Tetrahedron Letters 1979 pp. 3867-3868). In order to
prepare a carba-2-penem compound from penicillin, it is,
first of all~ necessary to establish an advantageous method
to replace the sulfur atom at the 4-position of the ~-
lactam ring of the penicillin with a suitable hydrocarbonresidue. In this respect, the prior art was successful,


'

I ~666~0
-- 2
taking advantage of the substitution reaction of chlorine
with allylcopper coMpound.- ~owever, the allylcopper
compounds employed in this prior art require treatment
under special conditions where moisture should be strictly
avoided, thus the technique disclosed in this prior art is
unlikely to be practical for industrialization. Besides,
the substituent which can be introduced into the 4-position
of the ~-lactam ring with the technique is restricted to
an allyl group, which inevitably requires a number of
following steps before obtaining the desired carba-2-penem
compound. Thus, although, a penicillin was successfully
used as the starting material, the drawbacks as mentioned
above make the technique be far from being economically
advantageous.
This invention relates to 2-oxoazetidine derivatives
represented by the formulai

Rl C -R3
~ \R4 (I)
NH

wherein Rl stands for phthalimido group, benzyloxycarbonyl-
amino group, a halogen or an alkyl group which may have
hydroxyl group, R2 stands for hydrogen, an alkyl group, an
alkylthio group or an arylthio group, and R and R
independently stand for an acyl group or cyano group, which
are important intermediates for the synthesis of carba-2-
penem-~-carboxylic acid derivatives, useful antibacterial
agents, and to a method of preparing same.
The present inventors found that a compound represented
by the formula (I) can be prepared by allowing a compound
represented by the formula;

1 166640

-- 3. -- .,

R /Cl
~--r
l (II)

S O CO-COOR

wherein Rl is o~ the same meaning as defined above, and R5
stands for a protective group of carboxyl group, to react
with a compound represented by the formula;
R
HC / R3 (III~
R
wherein R2, R3 and R are of the sàme meanings as defined
above, respectively, in the presence of an alcohol and a
base, and that various types of carba-2-penem-3-carboxylic
acids can be derived from compounds represented by the
formula (I) with economical advantage, thus accomplishing
the present invention.
In the above formula, as the al~yl group represented
by Rl, which may have hydroxyl group, there may be m2ntioned
straight-chain, branched or cyclic (Cl 8) one such as
methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-
butyl, t-butyl, n-pentyl, i~opentyl, n-hexyl, cyclopropyl,
cyclobutyl, cyclopentyl or cyclohexyl, and a lower alkyl
whose carbon number ranges from l to 6 is preferable. As
especially preferable one, there may be mentioned an alkyl
whose carbon number is l to 4. The hydroxyl group may be
attached to any of the suitable positions of these alkyl
groups, which are exemplified as straight-chain, branched
or cyclic lower hydroxy alkyl groupswhose carbon number is
in the range of from 2 to 6, such as l-hydroxyethyl, l-
hydroxyisopropyl, 2-hydroxyethyl, l-hydroxycyclobutan-l-yl,
l-hydroxypropan-l-yl or l-hydroxycyclohexan-l-yl. Such hydroxyl
groups may be protected with e.g. acetyl, chloroacetyl,
methylthiomethyl, 2,2,2-trichloroethoxycarbonyl, l,l,l-
triahloro-2-methyl-2-propoxycarbonyl, p-nitrobenzyloxy-


6 ~ 0
-- 4
carbonyl or allyloxycarbonyl. As the halogen representedby Rl, there may be mentioned chlorine, bromine or iodine.
As the alkyl group represented by R2, there may
be mentioned straight-chain or branched (Cl 6) alkyl such
as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl,
tert-butyl, pentyl, isopentyl, neopentyl or hexyl etc. As
preferable one there may be mentioned an alXyl whose carbon
number ranges 1 to 4.
As the alkylthio group represented by R2, there may,
for example, be mentioned a lower alkylthio group whose
carbon number ranges 1 to 6, such as methylthio, ethylthio,
propylthio, butylthio, pentylthio or hexylthio. As pre-
ferable one, there may be mentioned an alkylthio whose
carbon number is 1 to 4 and as the arylthio group r~presented
by R2, there may for example be mentioned phenylthio or
naphthylthio.
As the acyl group independently represented by R3 and R4,
there may be mentioned R6-CO- and R7-Co-, respectively. The
R6and R independently stand for (Cl 4) lower alkyl e.g. methyl,
ethyl, propyl or isopropyl; halogenomethyl e.g. chloromethyl
or bromomethyl; methylthiomethyl; arylthiomethyl e.g. phenyl-
thiomethyl or naphthylthiomethyl; carboxymethyl whose carboxyl
may be protected; a-diazocarboxymethyl whose carboxyl may be
protected; (Cl 4) lower alkoxy e.g. methoxy, ethoxy, propoxy,
isopropoxy, butoxy or t-butoxy; halogeno (Cl 4) lower alkoxy
e.g. 2,2,2-trichloroethoxy; aralkyloxy e.g. benzyloxy, p-
nitrobenzyloxy, or o-nitrobenzyloxy; (Cl 4) lower alkylthio e.g.
methylthio or ethylthio; amino ICl 4) lower alkylthio e.g. 2-
aminoethylthio whose amino group may be protected; or amino
(Cl 4) lower alkenylthio e.g. 2-aminoethynylthio whose amino
group maylbe protected.
As regards the protective groups in "the carboxyl
groups which may be protected" and in "the amino groups
which may be protected", reference can be made to, for
example, a known literature re~erence, e.g. "Protective
Groups in Organic Chemistry"; Plenum Press, N.Y., 1973,
compiled by J.F.W. McOmie. As the former, there may be

1 16664~


exemplified lower alkyl e.g. methyl; (C4_6) tertiary alkyl
e~g. 2,2,2-trichloroethyl or t-butyl; ~Cl 6) alkanoylmethyl
e.g. acetoxymethyl or pivaloyloxymethyl; N-phthalimido-
methyl; benzoylmethyl; benzyl; p-bromobenzyl; p-nitro-
benzyl; p-methoxybenzyl~; benzhydryl; trityl; aryl;
trimethylsilyl; or triethylsilyl. As the latter, there
may be exemplified monovalent protective groups e.g. t-
butoxycarbonyl, trichloroethoxycarbonyl, benzyloxycarbonyl,
p-methoxybenzyloxycarbonyl~ p-nitrobenzyloxycarbonyl,
isobornyloxycarbonyl, trityl or methyl acetoacetate adduct;
or divalent protective groups e.g. phthaloyl, succinyl,
maleyl or 4,5-diphenyl-4-oxazolin-2-one.
As examples of preferable one among acyl groups
represented by R6-CO- and R7-Co-, there may be mentioned
lower (Cl 4) alkylcarbonyl group, halogenoacetyl, carboxy-
acetyl, lower (Cl 4) alkoxycarbonylacetyl, arylthioacetyl,
lower (Cl 4) alkoxycarbonyl, halogeno lower (Cl 4) alkoxy-
carbonyl or 2-diazo-2-(2,~,2~trichloroethoxycarbonyl)acetyl.
- Selection of the protective groups to be employed is
within the discretion of the artisans in the relevant
technical field, and, the protective groups thus applied
can, dependingancases, be removed by appropriate reaction
steps.
Incidentally, free carboxyl groups of these compounds
may be salt~ with an alkali metal such as lithium, sodium,
potassium, etc., an alkali earth metal such as magnesium,
calcium, barium etc., protonated ammonia, primary amine
(for example methylamine, ethylamin, n-propylamine, iso-
butylamine, cyclohexylamin, etc.) or secondary amine (for
example dimethylamine, diethylamine, diisopropylamine,
dicyclohexylamine, etc.) or tertiary amine such as tri-
methylamine, triethylamine, tri-n-butylamine, pyridine,
etc., and free amino groups may be acid addition salts
with an inorganic acid such as hydrochloric acid, sulfuric
acid, phosphoric acid, etc., or an organic acid such as
maleic acid, acetic acid, citric acid, succinic acid,

- 1 1666~

-- 6 --
tartaric acid, malic acid, malonic acid, fumaric acid,
benzoic acid, mandelic acid, ascorbic acid, methanesulfonic
acid, etc.
A novel compound (I) of this invention can be prepared
by, for example, allowing a 2-(4-chloro-2-oxoazetidin-1-
yl)-2-oxoacetic acid derivative (II) to react with the
compound (III) in the presence of an alcohol and a base.
As the protective group of the carboxyl group represen~ed
by R in the above formula (I), use can be made o~, for
example, those as described on R3 and R4.
As the alcohol in the above reaction, use can prefer-
ably be made of a (Cl 4) lower alcohol such as methanol,
ethanol, propanol, isopropanol, butanol, isobutanol or t-
butanol.
As the base, organic or inorganic ones can be employed,
and most frequent use is made of alkali metal alcoholate
e.g. lithium methoxide, sodium methoxide or potassium-t-
butoxide; tertiary amine e.g. trieth~lamine, pyridine,
dimethylaniline, diisobutylethylamine or 1,5-diazabicyclo-
t4~3~0]non-5-enei alkali metal salt of secondary amine e.g.
sodium hexamethyl disilazane or lithium diisopropylamine;
alkali metal hydroxide e.g. sodium hydroxide; or alkali
metal carbonate e g. potassium carbonate.
The reaction is conducted in an organic solvent. As
the solvent, frequent use is ma~e of the above-mentioned
alcohols, tetrahydrofuran, dioxane, diethylether, dichloro-
methane and a suitable mixture thereof.
The reaction can be conducted preferably in the manner
described below.
Materials for the reaction are employed a 2-(4-chloro-
2-oxoazetidin -l-yl)oxoacetic acid derivative represented
by the formula (II), a compound represented by the formula
(III), an alcohol and a base, in the equivalent ratio of
1:1-3:1-10 (when an alcohol is used as a solvent, this range
may vary indefinitely): 1-3 in that order. These materials
are separatel~ or in a suitable combination dissolved in

1~664~1

a suitable solvent or solvents. Thus the solutions are
mixed together in a suitable order, whereby the reaction
proceeds. The reaction temperature is preferably kept
within the range from -78C to +5C. If desired, the
reactio~ is conducted in the streams of inert gas such as
nitrogen or argon. Usually, the reaction substantially
completes as soon as a compound (II), a compound (III),
an alcohol and a base are all assembled but the reaction
mixture may be stirred for further 0.5-5 hours.
After completion of the reaction, the object com-
pound (I) is recovered from the reaction mixture by per se
conventional manner. For example, dichloromethane and
ice~water are added to the reaction mixture, and the mix-
ture is made acidic, then the mixture is stirred vigorously,
followed by separation of the dichloromethane layer. The
layer is subjected to drying, followed by removal of the
solvent by evaporation thereby to obtain the object com-
pound (I).
Thus obtained object compound (I) can be purified by
per se conventional process, e.g. recrystallization, column-
chromatography or thin-layer chromatography.
2-Oxoazetidine compounds represented by the formula
(I) are useful as intermediates for carbapenem-3-carboxylic
acid derivatives useful as antibacterial agents. The
compounds (I) comprise optical isomers (e.g. [3R,4R]-isomer,
[3S,4S]-isomer, etc.). In these cases, the individual
isomers as well as a mixture thereof fall into the scope of
the present invention. The optically active compound [I]
is obtained by employing an optically active compound [II]
as starting material, or by optical resolution of the
recemic compound [I] which may be prepared from a racemic
compound [II].
2-(4-Chloro-2-oxoazetidin-l-yl)-2-oxoacetic acid
derivatives (II) employed as a material in this invention
can be prepared from a penicillin derivative (IV) by the
reaction schema as below:

~ 166649 ;.~

-- 8 --
(IV ~ ~1



(V)
R,~Cl

`r--

COOR
(II) '
By employing the compounds of the present invention
as starting materials, carba-2-penem compounds having
excellent anti-bacterial activity and ~-lactamase Inhibitory
activity (e.g. Thienamycin, --- Antimicrobial Agents and
Chemotherapy, 14, 436-438 (1978); Olivanic acid --- Journal
of Antibiotics, 33, 878-884 (1980); PS-5, --- Journal of
Antibiotics, 32, 272-279 (1979); and C-19393 H2, --- Dutch
laid open patent application No. 8000-628) can be synthesized
through the reaction schema as shown by the ~ollowing
Chart l and 2.
Chart 1

Rl C~CoR6 1) remval of R t ~ ~CH2COR OHc-COOP
o ~NH 2) decar~oxylation ~ NH

R ~ 2 ;SOC12 R ~ 2 l) Ph3P

\ OH \CHCl 2) base
COOPNB COOPNB



4 ~
~,

g

Rl CH COR6 Rl R6 remov~l of
~ 2 1~ ~ protecting group
- Nheating , ~ N ~ by reduction
COOPNB
C=PPh3
COOPNB


o~L N 11
COOH

(In the formula, Rl and R6 are of the same meanings as
defined above, R8 stands for a carboxyl-protecting group,
PNB stands for p-nitrobenzyl group, and Ph stands for
phenyl group.)
15 Chart 2 .
COOR8
Rl CH 1) removal of R and Rl . O
~CO 9 2) LRh(AC)2]2 O~ N~(cOOR9




p-toluenesulfonic ~ ~ s R t l ~ R6l
acid anhYdride . ~ N ~ g R H~ O" N ~ g
ase o COOR COOR

b~ ~ 1 of R9 ~ 1~


(In the formula, R8 and R9 respectively stand for a carboxyl-
protecting group, R6 stands for, among those defined as
R6, preferably alkylthio group, 2-aminoethylthio group
protected at amino group, or 2-aminoethenyl group protected
at amino group, Ts stands for p-toluenesulfonyl group, and
Ac stands for acetyl group.)
The present invention will be explained more concretely
by way of the following Reference Examples and Examples.

- ~16664~ ; j


NMR spectra were measured by employing Varian HA 100 Type
(100 MHz), EM 390 (90 MH2) or T 60 Type (60 MHz), and the
values are expressed in terms of ppm, taking tetramethyl-
silane as the standard. The abbreviations s, br.s, d, dd,
t, q, m, ABq, sh, J, DMSO, br and ar.denote respectively
singlet, broad singlet, doublet, double doublet, triplet,
quartet, multiplet, AB type quartet, shoulder, coupling
constant, dimethylsulfoxide, broad and aromatic.
In the following Reference Examples and Examples, the
elution in column chromatography wascarried out with
observation of TLC. In the TLC,were employed Merck TLC
plate 60F254, a developing solvent which is the same as the
eluent employed in the column chromatography and W detector.
Fractions containing the desired compound, which show
the same Rf value as..that of main spot appearing on TLC plate
at TLC for the reaction solution to be subjected to column
chromatography,werecollected.
The complete consumption of the starting material due
to introduction of ozone waschecked following the same
manner as Reference Example 6.
Reference Example 1
Pivaloyloxymethyl (3R,4S)-2-~4-(chloro-3-(1-hydroxyisopropyl)-
2-oxoazetidin -1-yl]-2-isopropylidenyl acetate
(a) Pivaloyloxymethyl 6~-formamidopenicillanate
2S . To a mixture con5isting of 113 g of pivaloyloxymethyl
6~-aminopenicillanate hydrochloride, 45 ml of triethylamine
and 500.ml o~ dichloromethane, which is previously cooled
with ice under stirring, is added dropwise a mixed anhydried
of acetic acid and formic acid, which is prepared by heating
a mixed solution of 30 ml of acetic anhydride and 30 ml of
formic acid at 60C for 15 minutes, while controlling the
reaction temperature not to exceed 20C. The reaction
mixture is stirred under ice-cooling for 20 minutes, which
is then concentrated under reduced pressure. To the con-
centrate is added 500 ml of ethyl acetate. The solution iswashed with water (twice with 300 ml-portion eac~), followed

- 1 16~40 ~ ;i;.

by shaking vigorously together with 500 ml of a 10% aqueous
solution of sodium hydrogen carbonate. Thirty minutes
later, pH of this mixture is adjusted to 7 with concentrated
hydrochloric acid (ca. 30 ml), followed ~y separating the
organic layer. The organic layer is washed with an aqueous
solution of sodium chloride, then dried over magnesium
sulfate, followed by concentration to leave 110 g of an oily
product.
(b) Pivaloyloxymethyl 6~-carbylaminopenicillanate
A mixture consisting of 110 g of the oily product
obtained in (a) above, 195 ml of pyridine and 300 ml of
dichloromethane is stirred at a temperature ranging from
~40C to -50C, to which is added dropwise 54 ml of phos-
phorous oxychloride over about 2 hours, followed by stirring
~or further one hour~at the same temperature. To the
reaction mixture is added 2 kg of crashed ice, and the
mixture is stirred for about 20 minutes. The organic layer
is separated, washed with an aqueous solution of sodium
chloride, dried over magnesium sulfate, and concentrated to
leave a syrupy product. Crystals separated out are collected
by filtration with ~uction to yield 53 g of crystals, m.p.
96.1C.
Elemental analysis: C15H20N2O5S
~ C(%) H(%) N(%)
: Calcd.: 52.93 5.92 8.23
Found : 52.36 6.27 7.99
IR Spectrum vmax(CHC13): 2990, 2150, 1800, 1760, 1115
and 1000 cm
NMR Spectrum (CDC13, 100 MHz) ~: 1.23(s,C(CH3)3),
1.54 and 1.69(each 2-C(CH3)2), 4.59(s,3-H), 5.22(d,
J=4Hz,6-H), 5.56(d,J=4Hz,5-H), 5.79 and 5.88(ABq,
J=6Hz,OcH2O)
[a]D ~ 153.2 (c=0.555, CH30H)
(c) Pivaloyloxymethyl 6~-1-hydroxyisopropyl-6~-carbyl-
aminopenicillanate
A mixture of 11.5 ~ of pyvaloyloxymethyl 63-

- ~166~40 .1,

- 12 -
carbylaminopenicillanate, 7 g of granular potassium
carbonate and 100 ml of acetone is stirred for 7 hours
under ice-cooling. The reaction mixture is subjected to
filtration with suction, and the filtrate is concentrated
to leave an oily substance, which is subjected to silica-
gel (300 g) column-chromatography by use of a mixture of
n-hexane and ethyl acetate (1:1) as an eluent. Fractions
containing the desirèd compound are collected and concen-
trated to leave 10 g of an oily substance, which is left
standing in a refrigerator to cause crystallization, followed
by loosening with n-hexane. The crystals are collected by
filtration with suction. m.p. 58-68C.
Elemental analysïs: C18H26N2O6S
C(~) H(~) N(%)
Calcd.: 54.25- 6.58 7.03
Found : 54.06 6'.80 7.06
IR Spectrum vmax(CHC13): 3550, 3400, 3000, 2140, 1795,
1760, 1110, 995 cm
NMR Spectrum (CDC13, 100 MHz) ~: 1.23(s,C(CH3131, 1-42
and 1.53(each s,(CH3)2CO), 1.53 and 1.66(each s,2-C-
~CH3)2), 2.58(s,0H), 4.58(s,3-H), 5.54(s,5-H), 4.78
and 4.89(ABq,Jz6Hz~OCH2O)
La]D + 149.2 (c=0.53, CH30H)
(d) Pivaloyloxymethyl 6~-1-hydroxyisopropylpenicillanate
A vessel containing a mixture of 39.8 g of pivaloyl-
oxymethyl 6-1-hydroxyisopropyl-6~-carbylaminopenlcillanate,
41 ml of tri-n-butyltin halide, 0.82 g of a,'-azo-bis-
isobutylonitrile and 200 ml!of toIuene is placed on an oil
bath heated at 85C, and the mixture is stirred for 30
minutes. The reaction mixture is concentrated under
reduced pressure. To the concentrate is added 250 ml of
n-hexane, and the mixture is stirred. Precipitating crystals
are collected by filtration, and recrystallized from n-
hexane-toluene to give 17.3 g of crystals, m p. 120.3C.
Elemental Analysis: C17H27NO6S

.1~6~6 4~

- 13 -
C(~) H(%)
Calcd.: 54.67 7.29
Found : 54.75 7.34
IR Spectrum vmax(CHC13): 3450, 2975, 1760, 1105, 985 cm 1
NMR Spectrum (CDC13, 100 MHz) ~: 1.23(s,C(CH3)3), 1.31,
1.44, 1.53 and 1.71(each s,2-C(CH3)2 and (CH3)2CO),
3.26(s,OH), 3.67(d,J=4.5Hz,6-H), 4.49(s,3-H), 5.48
(d,J=4 5Hz,5-H), 5.78 and 5.88(ABq,J=6Hz,OCH2O)
[~]D + 198.5 (c=0.595, CH30H)
(e) Pivaloyloxymethyl [3R,4S]-2-[4-chloro-3-(1-hydroxy-
isopropyl)-2-oxoazetidin-1-yl]-2-isopropylidenyl acetate
To a solution of 18.5 g of pyvaloyloxymethyl 6~
hydroxyisopropylpenicillanate in 150 ml of dichloromethane
which is kept at -20C with stirring is added dropwise
150 ml of 1 M chlorine-carbon tetrachloride solution. The
mixture is stirred for 5 minutes at -20C, then for 15
minutes at 0C, followed by addition of 200 ml of a 10~
aqueous solution of sodium hydrogen carbonate, and the mix-
ture is stirred. The organic layer is separated, dried- ~'
over magnesium sulfate and concentrated under reduced
pressure to leave an oily substnace,which is subjected to
column chromatography packed with 300 g of silica-gel, by
use of a mixture of n-hexane and ethyl acetate as an eluent.
Fractions containing the desired compound are collected
and concentrated to leave an oily substance. The oily sub-
stance is again subjected tocolumn chromatography under same
conditions to those above mentioned. The fractions contain-
ing the desired compound are treated with activated carbon,
followed by concentration to give 14.8 g of an oily product.
Elemental analysis: C17H26ClNO6
C(%) H(~) N(~) Cl(%)
Calcd.: 54.33 6.97 3.73 9.43
Found : 54.11 7.13 3.62 10.02
IR Spectrum vmax(CHC13): 3525, 2980, 1770, 1745, 1390,
1370, 1120, 990 cm 1
NMR Spectrum (CDC13, 100 MHz) ~: 1.24(s,C(CH3)3), 1.39

. li~6~4~

- 14 -
and 1.46(each s,(CH3)2CO), 2.06 and 2.33(each s,
C(CH3)2?, 2.48(s,OH), 3.47(d,J-1.6Hz,3-H), 5.77 and
5.87(ABq,J=6Hz,OCH2O), 5.83(d,J=1.6Hz,4-H)
- Reference Example 2
P-Nitrobenzyl [3S,4R~-2-[4-chloro-3-(1-hydroxyisopropyl)-
2-oxoazetidin-l-yl]-2-isopropylidenyl acetate
~- (a) A mixture of 27.1 g of p-nitrobenzyl 6~-amino~
penicillanate p-tQluenesulfonic acid salt, 250 ml of di-
chloromethane and 150 ml of water is stirred at a tempera-
ture ranging from -2C to 0C, to which is added 4.49 g
of sodium nitrite, followed by adding dropwise 50 ml of
1- N phosphoric acid over 30 minutes. The whole mixture is
stirred for further 30 minutes, then the organic layer is
separated. The aqueous layer is subjected to extraction
with 100 ml of dichloromethane. The extract is combined
with the said organic layer, which is washed with ice-
water, followed by concentration under reduced pressure.
The resulting oily subst~ace is dissolved în 4~00 ml of
acetone, which is stirred at a temperature ranging from
-2~C to 0C. To thus cooled solution is added dropwise a
mixture consisting of 60 ml of l N hydriodic acid and
13.4 g of sodium iodide over 30 minutes, then the whole
mixture is stirred for further 30 minutes. To the reaction
mixture is added 13 g of sodium hydrogen carbonate, and the
mixture is stirred. The whole mixture is subjected to
evaporation under reduced pressure to remove the solvent to
leave an oily substnace which is shaken together with 300 ml
of ethyl acetate and 300 ml of water. The organic layer is
separated, and washed with 200 ml of 1 N sodium thiosulfate
and then with a saturated aqueous solution of sodium
chloride, followed by drying on anhydrous magnesium sulfate,
which is concentrated to leave an oily substance. The oil
is purified by means of silica-gel column-chromatography
(n-hexane-ethyl acetate = 1:1 V/V). Franctions containing the
desired compound are collected and concentrated to leave
9.5 g of p-nitrobenzyl 6a-iodopenicillanate as an oily

1 ~fi66~
- 15 -
product. The product is left standing overnight in a
refrigerator to cause partial crystallisation, followed by
loosening the crystals with acetone-dichloromethane (1:1
V/V). The crystals thus recovered are authentic specimens
for analytical use. m.p. 98-100C.
Elemental analysi~: C15H15IN2O5S
C(~) H(%) N(%)
Calcd.: 38.98 3.27 6.06
Found : 39.05 3.23 6.29
IR Spectrum vmax~neat); 2980, 1780, 1750, 1610, 1520,
1450, 1350, 1290 cm
NMR Spectrum (CDC13, 100 MHz) ~: 1.43 and 1.65(each s,
C(CH3)2), 4.62(s,3-H), 5.03(d,J=1.5Hz,5-H), 5.32
(s,CH2), 5.47(d,J=1.5Hz,6-H), 7.56 and 8.26(each d,
J=9Hz,ar.H4)
(b) A solution of 462 mg of p-nitrobenzyl 6~-iodopenicil-
lanate in 5 ml o~ tetrahydrofuran is stirred at -73C, to
which is added 1.2 ml of lN methylmagnesium bromide-
tetrahydrofuran, followed by stirring for 10 minutes. To~
this mixture is added 2 ml of acetone, and the temperature
of the solution is raised up to -50C taking 20 minutes.
The temperature is again lowered to -70C, and to the
solution are added 3 ml of saturated aqueous ammonium
chloride solution and 10 ml of ethyl acetate, followed by
vigorous stirring. The organic layer is separated and
washed with a saturated aqueous solution of sodium chloride,
and dried over magnesium sulfate. The crude product
obtained by removing the solvent by evaporation, is
purified by means of silica-gel column chromatography
(dichloromethane-ethyl acetate = (10:1)). Fractions containing
the desired compound are collected and concentrated to
leave 94 mg of p-nitrobenzyl 6~-1-hydroxyisopropylpenlcil-
lanate.
IR Spectrum vmax(KBr): 3500, 1770, 1755, 1525 cm 1
NMR Spectrum (CDC13, 60 MHz) ~: 1.32 and 1.60(each s,
2-(C(CH3)2), 1.36(s,(CH3)2CO), 2.42(br.s,0H), 3 40

116664~
- 16 -
(d,J-l.OHz,6-~), 4.59(s~3~H), 5.34(d,J=l.OHz,5-H),
5.34(s,CH2), 7.5-8.4(m,ar.~4)
(c) A solution of 98 mg of p-nitrobenzyl 6a-1-hydroxy-
isopropylpenicillanate in 2 ml of dichloromethane is
S stirred at -40C, to which is added dropwise 1.65 ml of
0.45 M solution of chlorine-car~on tetrachloride. The
mixture is stirred for 20 mi~utes at the same temperature,
to which are added 10 ml of a 10~ a~ueous solution of sodium
hydrogen carbonate and 20 ml of dichloromethane, then the
whole mixture is vigorously shaken. The organic layer is
separated, washed with water, then subjected to evaporation
to remove the solvent. The resulting crude product is
purified by means of silica gel column chromatography (dichloro-
methane-ethyl acetate = 10:1) to yield 39 mg of p-nitrobenzyl
15 [3S,4R]~2-[4-chloro-3-(1-hydroxyisopropyl)-2-oxoazetidin-
l-yl]-2-isopropylidenyl acetate as an oily product.
IR Spectrum v (film): 3475(br.), 1i70,-1726, 1520 cm 1
max
NMR Spectrum (CDCi3, 60 MHz) ~; I.34 ard 1.44(each s,
(CH3)2CO), 1.94(br.s,OH), 2.06 and 2.32(each s,
(CH3)2C=), 3.47(d,J=1.5Hz,3-H), 5.30(s,CH2), 5.82
(d,J=1.5Hz,4-H), 7.44-8.32(m,ar.H4)
Reference Example 3
Methyl [3S,4R]-2-(4-chloro-3-phthalimido-2-oxoazetidin-
l-yl)-2-isopropylidenylacetate
A solution of 180 g of methyl 6a-phthalimidopenicil
lanate in 750 ml of dichloromethane is stirred at a tem-
perature ranging from -55C to -45C, to which is added
dropwise 750 ml of 2 Mol solution of chlorine-carbon
tetrachloride over about 40 minutes. Twenty minutes later,
the temperature of the reaction mixture is raised up to
-10C during one hour. The solvent is distilled off under
reduced pressure.
To the residue is added 200 ml of dichloromethane,
which is concentrated under reduced pressure. To the
residue is again added 200 ml of dichloromethane, which
is concentrated under reduced pressure. To the residue is

~16~640
- 17 -
added 200 ml of methanol, which is concentrated under
reduced pressure. The residue is dissolved in 400 ml of
methanol while warming, followed by left standing in a
refrigerator. -The precipitating crystals are collected
by filtration with suction to give 140 g of the titled
compound. m.p. 122-124C.
Elemental analysis: C17H15ClN2O5
C(%) H(%) N(%)
Calcd.: 56.29 4.17 7.72
Found : 55.88 4.10 7.52
TLC, Rf; 0.31/n-hexane-AcO~t=2:1, (Merck T~C plate
60 F254, Germany~ -1
IR Spectrum Vmax(KBr): 1790, 1780, 1725, 1630, 1400 cm
NMR Spectrum (CDC13, 100 MHz) ~: 2.10 and 2.35(each s,
(CH3)2C=), 3.87(s,CH30), 5.59 and 6.25(each d,J=1.5Hz,
3-H & 4-H), 7.7-8.0(m,ar.H4)
[ ]23+ 115 3 (c=1.13, CHC13)
Reference Example 4
Methyl [3S,4R]-2-(4-chloro-3-bromo-2-oxoazetidin-1-yl)-2-~
-
isopropylidenylacetate
A solution of 14.7 g of methyl 6~-bromopenicillanate
in 100 ml of dichloromethane is stirred at -50C, to which
is added dropwise 200 ml of 1 ~ol solution of chlorine-
carbon tetrachloride over 30 minutes. During 3 hours the
temperature of the reaction mixture is raised to 10C. The
mixture is concentrated under reduced pressure. To the
residue is added 30 ml of dichloromethane, which is con-
centrated under reduced pressure. To the residue is again
added 30 ml of dichloromethane, which is concentrated under
reduced pressure. The crude product thus obtained is
purified by subjecting to silica-gel volumn chromatography (n-
hexane -ethyl acetate = 2:1) to give 14.5 g of the titled
compound as an oily substance, which is left standing to
cause partial crystallization, m.p. 38-40C.
Elemental analysis: ClgHllBrClNO3

1 1~6640
- 18 -
C(~) H(~) N(~)
Calcd.: 36.45 3.74 4.72
Found : 36.13 3.64 4.99
IR Spectrum vmax(KBr): 3010, 2960, 1790, 1730, l630
1440, 1385, 1375 cm 1
NMR Spectrum (CC14, 60 MH7.) ~ 2.00 and 2.33(each s,
(CH3)3C-), 3.79(s,CH30), 4.82 and 5.78(each d,J=lHz,
3-H and 4-H)
Reference Example 5
.
p-Nitrobenzyl ~3S,4R]-2-(4-chloro-3-iodo-2-oxoazetidin-1-
yl)-2-isopropylidenylacetate
A solution of 2.31 g of p-nitrobenzyl 6~-lodopenicil-
lanate in 15 ml of dichloromethane is stirred at a t~mpera-
ture ranging from -30C to -20C, to which is added drop-
wise 30 ml of 0.9 Mol solution of chlorine-carbon tetra-
chloride over 30 minutes. The temperature of the mixture
is allowed to rise to 0C during l hour, then the mixture
is concentrated under reduced pressure. To-the residue
are added 30 ml of dichloromethane and 2.8 ml of triethyl-~;
amine, and the mixture is stirred for 2 hours under ice-
cooling. The mixture is shaken together with 70 ml of
dichloromethane and 30 ml of 1 N-hydrochloric acid. The
organic layer is separated, washed with a saturated aqueous
solution of sodium chloride (30 ml x3), dried over magnesium
sulfate, followed by concentration under reduced pressure.
The resulting crude product is purified by means of silica
gel column-chromatography (dichloromethane-ethyl acetate =
10:1 V/V) to give 1.264 g of the titled compound as crystals,
m.p. ll9-120~C.
Elemental analysis: C15H14ClIN2O5
C(~) H(%) N(%)
Calcd.: 38.78 3.04 6.03
Found : 38.71 2.98 5.88
IR Spectrum vmax(neat): 3000, 1780, 1730, 1610, 1520,
1390, 1350, 1280 cm 1
NMR Spectrum (CDC13, 100 MHz) ~: 2.08 and 2.35(s,C(CH3)2),

6~
- 19 -
5.23(s,CH2), 5.05(d,J=1.5Hz,4-H), 5.80(d,J=1.5Hz,
3-H), 7.56 and 8.24(each d,J=9Hz,ar.H4)
[a]D + 8.7 (c=l.ll, CHC13)
Reference Example 6
Methyl-~3S,4R]-2-(4-chloro-3-phthalimido-2-oxoazetidin-1-
yl)~2-oxoacetate
- A solution Qf 2.2 g of methyll3S,4R~-2-(4-chloro-3-
phthalimido-2-oxoazetidin-1-yl)-2-isopropylidenylacetate
~ ` in 60 ml of dichloromethane is stirred at -78C, Qzone is
- 10 allowed t~ pass through the solution for 30 minutes (com-
plete consumption of the starting material is~observed by
means of TLC (Merck TLC-palte 60 F254,~developing solvent;
n-hexane-AcOEt (2:1), U.V. detector), then nitrogen gas
is allowed to pass through ~he reaction mixture for 1 hour.
The reaction mixture is shaken together with 5 ml of an` ~`
aqueous solution of 0.5 g of sodium hyposulfite. The
~- ~organic layer is separated, washed with a saturated
aqueous solution of sodium chloride dried over magnesium
~ ~sulfate, and concentrated under reduced pressure. The ~r:
; 20 residue is mixed with n-hexane cooled at a temperature
ranging from -40C to -50C. The resultlng powder is
collected by filtration to yield 2.1 g of the titled com-
pound, m.p. 49-52C.
IR Spectrum Vmax(KBr): 2960, 1835, 1780, 1760, 1720,
1400, 1350, 1260 cm 1
NMR Spectrum (CDC13, 60 MHz) ~: 4.03(s,CH3), 5.73 and
6.33(each d,3-H & 4-H), 7.88(s,ar.H4)
t ]21-5 34 2 (c=0.9 Dioxane)
Reference Example 7
t-Butyl 2,2,2-trichloroethyl acetonedicarboxylate
A solution of 21 g of N,N'-carbodiimidazole in 200 ml
of dichloromethane is stirred under ice-cooling, to which
is added dropwise a solution of 18.7 g of t-butyl malonate
in 5 ml of dichloromethane, followed by stirring for 1.5
;~-35 hours. This solution is added dropwise to an ice-cooled,
stirred solution consisting of 16 g of Meldrum's Acid, 28 g

1 1~6640
- 20 -
of pyridine and 200 ml of dichloromethane over 15 minutes.
The mixture is stirred for one hour under ice-cooling,
then another one hour at room temperature. This mixture
is shaken with 200 ml of 5 N sulfuric acid and 100 ml of
water. The organic layer is washed with a saturated
aqueous solution of sodium chloride, dried over magnesium
sulfate, and concentrated under reduced pressure. A solu-
tion consisting of the oily residue, 41 g of 2,2,2-tri-
chioroethanol and 300 ml of benzene is subjected to reflux
for 25 minutes. The solvent is distilled off under reduced
pressure, and the oily residue is dissolved in 200 ml of
ethyl acetate, washed with a 10~ aqueous solution of sodium
carbonzte and then with a saturated aqueous solution of
sodium chloride, and dried over magnesium sulfate. The
solvent is distilled off under reduced pressure. The
oily residue is mixed with 10 ml of petroleum ether, which
is left standing at a refrigerator, the~ crystals precipi-
tate ~ut. This mixture is stirred with 10 ml of cooled
petroleum ether, followed by filtration with suction to
yield 17 g of thetitled compound as crystalline powder,
m.p. 50-52C.
Elemental analysis: C11H15C13O4 H2O
C(%) H(%) C1(%)
Calcd.: 39.37 5.11 31.59
Found : 39.27 4.52 31.63
I~ Spectrum vma~(XBr): 2990, 1750, 1730, 1350, 1290,
117~, 1125, 975, 815, 715 cm 1
NMR Spectrum (CDC13, 60 MHz) ~: 1.48(s,C(CH3)3), 3.60(s,
CH2C02t-Bu), 3.83(s,CH2C02CH2CC13), 4.87(S,cH2cc13)
Reference Example 8
2,2,2-Trichloroethyl 2-(2-t-butoxycarbonylacetyl)-2-
diazoacetate
A solution consisting of 1.6 g of t-butyl 2,2,2-
trichloroethyl acetonedicarboxylate, 0.985 g of tosyl azide
and 10 ml of ether is stirred under ice-cooling, to which
is added dropwise 0.7 ml of triethylamine, followed by

1 lB6640
- 21 ~
stirring for 15 minutes under ice-cooling and for 30
minutes at room temperature. The reaction mixture is mixed
with 10 ml of petroleum ether, which is then stirred for
15 minutes under ice-cooling. Toluenesulfonamide precipi-
tated is removed by filtration with suction, and thefiltrate is washed with 0.5 N hydrochloride acid, dried
over magnesium sulfate, followed by concentration under
-reduced pressure. ~he oily residue i-s dissolved in 3 ml
of carbon tetrachloride, an~ ~r.solubles ara removed by
filtration with suction. The filtrate is concentrated
to dryness under reduced pressure to give 1.52 g (yield
88.5%) of the titled compound as an oily substance.
IR Spectrum vmax(CC14): 2990, 2150, 1730, 1670, I370,
1330, 1140, 1050, 720 cm
NMR Spectrum (CC14,60 MHz) C: 1.43(s,C(CH3)3), 3.70(s,
CH2C02), 490(s,CH2CC13)
Reference~Exmaple 9
p-Nitrobenzyl 2-ethylthiocarbonyl-2-phenylthioacetate
A solution consisting of 435 mg of p-nitrobenzyl 2-~
ethylthiocarbonylacetate, 377 mg of N-phenylthiosuccinimide
and 5 ml of dichloromethane is stirred under ice-cooling,
to which is added dropwise a solution of 0.25 ml of tri-
ethylamine in 2 ml of dichloromethane. The solution is
stirred for one hour, washed with 1 N hydrochloric acid
and then with a saturated aqueous solution of sodium
chloride, dried over magnesium sulfate, followed by
concentration to dryness under reduced pressure. The oily
residue is purifiéd by means of silica-gel column chromato-
graphy (n-hexane -ethyl acetate =3:7), and the fractions
containing the desired product are collected and concen- -
trated to dryness to yield 504 mg (yield 84%) of the titled
compound as an oily substance.
IR Spectrumv maX(neat): 1750, 1675, 1610, 1520 cm 1
NMR Spectrum (CDC13, 60 MHz): ~ 1.22(t,J=7Hz,CH2CH3),
2.94(q,J=7Hz,CH2CH3), 4.76(s,CH), 5.32(s,CH2O),
7.24-8.36(m,ar.H4)

- 22 ~ 6840

Reference Example 10
Di-t-butyl 2-dlazoacetonedicarboxylate
A solution consisting of 2.6 g of di-t-butyl acetonedicarboxy-
late, 2 g of tosyl azide, 1.4 ml of triethylamine and 40 ml of
ether is stirred for 16 hours at room temperature, which is mixed
with 40 ml of ethyl acetate. The mixture is washed with 50 ml of
water, then with a saturated aqueous solution of sodium chloride
(50 ml x 2), and dried over magnesium sulfate, followed by concen-
tration under reduced pressure to the half volume. Then toluene-
sulfonamide precipitated is removed by filtration with suction,
and the filtrate is concentrated to dryness under reduced pressure.
The oily residue is subjected to silicagel column chromatography
(dichloromethane), and the fractions containing the desired product
are collected, which is concentrated to dryness under reduced pres-
sure to give 2.6 g (yield 96~ of the titled compound as an oily
substance.
IR Spectrum ~maX(neat): 2990, 2140, 1740(sh), 1720, 1660,
1480, 1460, 1~00 c~-l
NMR Spectrum (CDC13, 60 MHz) ~ : 1.46(s,C(CH3)3), 1.50
(s,C(CH3)3), 3.73(s,CH2CO2)
Reference Example 11
Bis(p-nitrobenzyl) acetonedicarboxylate
A mixture of 1.0 g of citric anhydride and 5 ml of dichloro-
ethane is stirred, to which is added dropwise 1.1 ml of chloro-
sulfonic acid. The mixture is stirred for one hour and left
standing overnight. The mixture is then stirred under ice-cooling,

- 23 - 1166~

to which is added a mixture consisting of 6 g of p-n~trobenzylal-
cohol and 30 ml of dichloroethane, followed by stirring at room
temperature. The reaction mixture is poured into cracked ice and
stirred. The organic layer is separated, washed with water twice,
dried over anhydrous magnesium sulfate, and concentrated under
reduced pressure. The oily residue is subjected to silica-gel
column-chromatography twice (first: dichloromethane-ethyl acetate =
19:1, second: dichloromethane-n-hexane-ethyl acetate = 17:2:1).
The fractions containing the desired product are combined, which
is concentrated to dryness to give 1.04 g (yield 48%) of the titled
compound as crystals, m.p. 85-87C.

IR Spectrum vmax(Ksr): 1758, 1735, 1724, 1612, 1520 cm 1
NMR Spectrum (CDC13, 60 MHz) ~ : 3.80(s,2 x CH2~, 5.36(s,
2 x OCH2-ar.), 7.98(ABq,J=9 & 42 Hz,ar.H8)
Reference Example 12
Methyl [3R,4S]-2-(4-chloro-3-phthalimido-2-oxoazetidin-
l-yl)-2-oxoacetate
.
A solution of 1.8 g of methyl [3R,4S]-2-(4-chloro-3-phthali-
mido-2-oxoazetidin-1-yl)-2-isopropylidenylacetate, prepared accord-
ing to procedures described in "Can. J. Chem., 50, 2894 (1972)
(W. Wolfe et al.,)", in 35 ml of dichloromethane is stirred at
-78C, and ozone is allowed to pass through the solution for 20
minutes, then nitrogen gas is allowed to pass through the solution
for 1 hour. The reaction solution is shaken with 5 ml of an
aqueous solution of 0.5 g of sodium bisulfite. The organic layer
is separated, washed with a saturated aqueous solution of sodium
chloride, dried over anhydrous magnesium sulfate and concentrated
under reduced pressure to afford the titled compound

~ ~6~40
- 23a -

IR Spectrum vmax(KBr): 3450, 2975, 1840, 1780, 1760
1720, 1400, 1350, 1260, 1200,
1130, 1100, 970, 795, 770,
720 cm 1
NMR Spectrum (CDC13, 60 MHz) ~: 3.98(s,OCH3), 5.70(d,
J=2.4Hz,3-H), 6.22(d,J=2.4Hz,4-H), 7.88(s,aromatic)
[~]24-5= +41 8 (c=0.685, CHC13)
Reference Example 13
Methyl [3R,4R]-2-(3-benzyloxycarbonylamino-4-chloro-2-
oxoazetidin-l-yl)-2-isopropylidenylacet-ate
A solution of 55 g of methyl 6~-benzyloxycarbonyl-

116~640

- 24 -
aminopenicillanate in 200 ml of dichloromethane is stirred
at -78C, to which is added dropwise 470 ml of 1 Mol
chlorine-carbon tetrachloride solution over 20 min. After
raising the temperature of the solution to 0C during
1 hr, the solution is concentrated under reduced pressure.
The residue is subjected to silica-gel chromatography by
use of n-hexane-ethyl acetate (2:1) as an eluent. The frac-
tions containing the desired compound are collected and
concentrated to afford the titled compound as an oil.
1~ IR Spectrum vmax(neat): 3350, 1780, 1730, 1700 cm
NMR Spectrum (CDC13, 60 MHz) ~: 2.00 & 2.26(each s,
C(CH3)2), 3.70(s,0CH3), 4.85(q,J=2 ~ 9Hz,3-H~,
5.15(s,OCH2), 5.80(d,J=2Hz,4-H), 6.25(d,J=9Hz,NH),
7.30(s,aromatic H5)
TLC, Rf; 0.36/n-hexane: AcoEt =2:1, Merck TLC plate
60 F254, (Germany)
Example 1
[3S,4S]-4-Bisacetylmethyl-3-(1-hydroxyisopropyl)-2~oxo-
_
azetidine
A solution of 1.5 g (4 mMol) of pivaloyloxymethyl
[3R,4S]-2-~4-chloro-3-(1-hydroxyisopropyl)-2-oxoazetidin-
l-yl]-2-isopropylidenylacetate in 50 ml of dichloromethane
is stirred at -78C, to which is introduced ozone for 15
minutes. Consumption of the starting material is cofirmed
by means of thin-layer chromatography. Introduction of
nitrogen gas into the reaction mixture for 30 minutes
gives a solution containing pivaloyloxymethyl [3R,4S~-2-
[4-chloro-3-(1-hydroxyisopropyl)-2-oxoazetidin-1-yl]-2-
oxoacetate. This solution is stirred at -10C, to which
are added 800 mg (8 mMol) of acetylacetone, then 20 ml of
methanol dissolving 216 mg (4 mMol) of sodium methylate.
The solvent is distilled off under reduced pressure, and
the residue is stirred vigorously together with 20 ml of
ethyl acetate, 1 ml of 1 N-hydrochloric acid and 10 ml of
a saturated aqueous solution of sodium chloride. The
organic layer is separated, dried over magnesium sulfate,

lI66~
- 25 -


and concentrated. The resulting reaction product is subjected to
silica-gel column-chromatograph~ (n-hexane-ethyl acetate 1:1 -
1:4). The fractions containing the desired product are combined
and concentrated to give 80 mg of the titled compound as crystals,
m.p. 109-110C.
Elemental analysis: CllHl 7NO4

C(%) H(~) N(~)
Calcd.: 55.91 7.68 5.93
Found : 55.86 7.37 6.02
IR Spectrum ~max(KBr): 3350, 3175, 3120, 1740~ 1700,

1360, 1180, 965, 840 cm~l
NMR Spectrum (CDC13, 90 MHz) ~: 1.27 and 1.30(each s,
C(CH3)2), 1.7 (br.s,OH), 2.23 and 2.30(each s,2xCOCH3),
2.90(d,J=1.8Hz,3-H), 3.82(d,J=9Hz,CH), 4.41(q,J=1.8
and 9Hz,4-H), 6.20(br.NH)
Example 2-4
In place of acetylacetone in Example 1, 8 mMol each of
carbon acids having the formula, C ~ ~, wherein R2, R3 and R4
are respectively as defined in the following table, is employed,
and the procedure of Example 1 is repeated to give the correspond-
ing 4-substituted-2-oxoazetidines as shown in the following table
involving their physico-chemical constants as well.




,~

1 lB664~

-- 26 ~



S ~ ~ C - R IP SpeCtr 1 ~IUR Spectru
R2 R3R4
.
2 HCH3CO- CH30CO- (K~r):3450, (CDC13,60MHz): _
3350,2980, 1.28(m,C(CH3)2),
~ 1750,1730, 2.27 & 2.33(each
1440,1385, s,CH3CO),2.62(br.
1370,1310 s,OH),3.00(d,J=1.6
Hz,3-H),3.62(d,
J=8Hz,CH), 3.77(s,
CH30), 4.11(dd,J=
1.6 ~ 8Hz,4-H),
6.47(br.s,NH)
.
3 H -CN -CN (KBr):3350, (CD30D,90MHz):
2990,2200 1.27 & 1.35(each
1760,1690, s,C(CH3)2), 2.87
1650,1380, (s,OH), 3.23(d,J~
1170 1.8Hz,3-H),4.07 ~:
(d,J=7.2Hz,CH),
4.21(dd,J=1.8 &
7.2Hz,4-H), 6.68
~d,J=1.8Hz,NH)
_ _~_ .
4 C H S- C H SCO- O N ~ CH OCO- (~Br): 3420 ~CDC13, 60MHz): +8.9
6 5 2 5 2 2 1762,1740, 1.26 & 1.29(each (0.66,
1662,1525 t,J=7Hz,CH2CH3), chloro-
1.36(s,C(CH ~ ), ~orm
2.33 & 2.65(each
br.s,OH), 2.92 &
2.95(each q,J=
7Hz,CH2CH3), 3.32
& 3.~each d,J'
2Hz,4-H), 4.32(d,
J=2Hz,3-H), 4.75
& 4.95(each ABq, .
2H,J=13.33&13.23
Hz,OCH2), 6.30 &
6.50(each br.s,
NH), 7.10-8.20

(m,ar.H4)

664~


Example 5
[3R,4R]-4~ Acetyl-l-methoxycarbonyl)methyl-3-phthalimido-
2-oxoazetidine
A mixture of 348 mg (3 mMol) of methyl acetoacetate
and 5 ml of 0.2 Mol methanolic sodium methylate is stirred
at -78C, ~o which is added dropwise a solution of 336 mg
(1 mMol) of methyl ~3S,4R]-2-(4-chloro-3-phthalimido-2-
oxoazetidin-l-yl)-2-oxoacetaie in 2 ml of tetrahydrofuran.
To the mixture is added 60 mg of acetic acid, followed by
concentration under reduced pressure. The residue is
shaken together with 20 ml of ethyl acetate and 10 ml of a
saturated aqueous solution of sodium chloride. The organic
layer is separated, and dried over magnesium sulfate,
followed by concentration. The resulting reaction product
is subjected to silica-gel column-chromatography (n-hexane-
ethyl acetate =1:1 -1:4 ~/V). The fractions containing
desired product are combined -and~concentrated-to give
227 mg of thé-titled compound~as crystals, m.p. 160-150.5C
tdecomp.)
Elemental analysis: C16H14N2O6 0.25H2O
C(%) H(%) N(%)
Calcd.: 57.40 4.37 8.37
Found : 57.23 4.26 8.23
IR Spectrum vmax(KBr): 3300, 1790, 1770, 1740, 1710,
1400, 730 cm
NMR Spectrum (d6-DMSO) 90 MHz) ~: 2.23 & 2.27(each s,
CH3CO), 3.27(br.s,OH), 3.58 & 3.70(each s,OCH3),
4.32(s,4-H), 5.23(s,3-H), 7.90(s,ar.H4), 8.67(s,NH)
Thin layer chromatography on silica gel plate
60 F2s4(Merck, Germany) Rf=0.12 (n-hexane: AcOEt=l:l)
Example 6-14
In place of methyl acetoacetate in Exam~le 5, 3 mMol
each of carbon acids having the formula CH~R3, wherein
R , R3 and R4 are respectively as defined in the following
table is employed, and the procedure of Example 5 is
repeated to give the corresponding [3R,4R]-4-substituted-


1166~4
- 28 -
3-phthalimido-2-oxoazetidines as shown in the following
table involvingphysico-chemical constants as well.

,R23 _ _
5 Ex. ~N ~NH \R4 Spectrum NMR Spectrum c,sol-
No. O O V cm-l ~ vent?
R ! R3 - R
_ __ ....... _. ,. I
6 H CH3CO- CH3CO- (KBr): 3275, (d7-DMF~9oMHz~:2.3o +12.3
1780, 1770, & 2.32(each s,CH3), (0.43,
1750, 1710, 4.45(dd,J=2.4&9Hz~ dioxane)
1400, 1360, A-H), 4.62(d,J=9Hz,
1280, 720 CH),:5.22(d,J=2.4
Hz,3-H), 7.92(ar.
H4), 8.57(s,NH)
7 H ClCH2CO- C H OCO- (KBr): 3290, (d6-DMSO,90MHzj:1.08 -45.8
2 5 2990, 2950, & 1.22(each t,J=6Hz, (0.38,
1785, 1760, CH3), 3.9-4.6(m, dioxane)
1740, 1710, -CH2Me, &CH),4.40(s,
1390, 1190 4-H),4.63(s,CLCH2CO),
725 5.25(d,J=2.4Hz,3-H),
7.92(s,ar.H4),8.63& L
8.72(each s,NH)
_~ _ .
8 H C~13CO- ( 3)3 (CHC13):1785, (CDC13,90MHz):1.42&
1730, 1400, 1.50(each s,C(CH3)3),
1375, 1300, 2.33(s,CH3CO),3.72
1145 (q,J=2.4 &9Hz,COCH-
CO), 4.51(q,J-2.4 &
9Hz,COCHCO),4.56(q,
J=2.4 &9Hz,4-H),5.05
&5.18(eachd,J=2.4Hz
3-H),6.45(br.s,NH),
7.65-7.95(m,ar.H4)
. _
9 H CH OCO- O O (KBr): 3350, (CD3CN,90~z):3.57, +14.2
3 ,. " 2970, 2150, 3.67, 3.78&3.80 (0.26,
CH OC-C-C 1795, 1765, (eachs, 2xCH3),4.33- diox~ane)
N2 1725, 1710, 4.53(m-4H), 4.75(d,
1660, 1390, J=9Hz,l/2CH of di-
1340, 1200 astereoisomer), 4.78
(d,J=7.5Hz,1/2CH of
diastereoisomer),
5.25 &5.32(each d,
J=2.4Hz,3-H), 6.82 &
6.93(each br.s,NH),
7.83(s,ar.H4)

6 4 V

.


- ~ -R23 IR NMR Spectrum I D
~ ~ R4 Spectrum ~ (c,sol-
Ex. ~_- ~ o~~NH V cm~l ven~)
5 No. O max
. l
R2 R3 R4 _ _
.
H C H SCO- O N ~ CH OCO- (KBr):3400, (CDC13+d6-DMSO, +35.5
2 5 2 2 L786, 1768, 60MHz): 1.24(t,J= (1.04,
1730, 1720, 7Hz,CH2), 2.96(q, dioxane)
10 1670 J=7Hz,CH2), 4.11(d,
J=9Hz,CH), 4.58(dd,
J=2 &9Hz,4-H),
5.20(br,s,3-H &
--CH2-(PNB), 7.24-
8.10(m,ar.H8),8.30
(s,NH) _
15 11 C H S- t- t- (KBr):3400, (CDC13,60MHz):1.47
6 S C H OCO- C4H OCOCH2CO- 1788, 1726, & l.S4(each s,
4 9 9 1395 2xC(CH3)3), 3.80 &
3.94(ABq~& t,J=
16.32 & 16Hz,
total 2H,CH2)~ ;~
4.38 &4.55(each d,
J=2.5Hz,total lH,
4-H), 5.67 &5.76
(each d,J-2.5Hz,
total lH,3-H),
6.25 &6.53(each
br.s.lH,NH), 7.02
-7.81(m,9H,ar.)

12 H- ClCEI CO- t-C H OCO- (KBr):3350, (CDC13,60MHz):
2 4 9 2990, 2950, 1.42(s,C(CH3)3),
1780, 1770, 4.17(d,J=9Hz,
1760, 1740, COCHCO), 4.40(s,
1730, 1715, ClCH2CO), 4.70(dd,
1390, 1370 J=2.8 &9Hz,4-H),
5.33(d,J-2.3Hz,
3-H), 5.70(br.s.
NH), 7.90 & 7.93
_ _ (2xs,ar.H4)




1 lBB64~
- 30 -


_ O ,R23 ~ ~ ~ D
Ex. ~ ~ ~NH Spectrum ~ (c,sol-
5 No. O O V cm~~ vent)
.
R2R3 R4
.

13 H- C H SCH2CO- C2H OCO- (KBr):3350, ~CDC13,60MHz): +5.9
6 5 5 2990, 1785, 1.17 &'1.23~2xt, t0.56,
1720, 1390, J=7.5Hz,CH2CH3), dioxane)
720 4.02(s,SCH2),
3.9-4.3(m,4-H &
CH2CH3), 4 50 &
~53(2xd,J=lOHz,
COCHCO), -5.23 ~
5.33(2xd,J=2.8Hz,
3-H), 6.57 &
7.00(2xbr.s,NH),
7.42 (s,C6Hs),
7.90 & 7.93(2xs,
- . ~ phthalimldo ~14)
. _ , _ _.
14 C6H5S- CH OCO- Cl CCH2OCO- (KBr):3300, (CDC13,90MHz): +40.9~
3 3 2960, 1800, 3.67 & 3.78(2s, (1.22~',
2 1770, 1720, CH3), 4.55 &4.85 chloro-
1400, 1260, (ABq,J=12H7, form)
160, 790 CH2CC13), 4.72 &
760, 725 4.75(2d,J=2.4Hz,
4-H), 5.82 & 5.85
(2d,J=2.4Hz,3-H),
6.33(br.s,NH),
7.2-8.0~m,ar.H4)
_
Example 15
[3R,4R]-3-Bromo-4-(1-acetyl-1-t-butyloxycarbonyl)methyl-2-
oxoazetidine
A solution of 890 mg (3 mMol) of methyl [3S,4R]-2- -
(3-bromo-4-chloro-2-oxoazetidin-1-yl)-2-isopropylidenyl-
acetate in 60 ml of dichloromethane is stirred at -78C.
Ozone is allowed to pass through the solution for one hour.
Consumption of the starting material is confirmed by means
3~ of thin-layer chromatography. Then, nitrogen gas is
allowed to pass through the reaction mixture for 30 minutes

~ 166640
- 31 -

to give a solu-tion of methyl [3S,4R]-2-(3-bromo-4-chloro-2-oxo-
azetidin-l-yl)-2-oxoacetate. This solution is cooled to -78C,
to which is added dropwise a mixture of 0.497 ml of t-butyl aceto-
acetate and 15 ml of 0.2N-methanolic sodium methylate, followed
by stirring for 20 minutes. To the mixture is added 0.5 ml of
acetic acid, then the reaction mixture is concentrated under re-
duced pressure. The oily residue is shaken together with 200 ml
of ethyl acetate and 50 ml of water. The organic layer is separ-
ated, washed with a saturated aqueous solution of sodium chloride
(3 x 20 ml), dried over magnesium sulfate, and concentrated under
reduced pressure. The resulting product is subjected to silica-
gel column-chromatography (n-hexane:ethyl acetate = 1:1). The
fractions containing the desired compound are combined, and con-
centrated to give 670 mg of the titled compound as an oily sub-
stance.
Elemental analysis: CllH16BrNO4.H2O
C(%) H(%) N(%)
Calcd.: 40.77 5.60 4.32
Found : 40.93 5.06 3.81
IR Spectrum ~maX(neat): 3300, 2995, 1780, 1720, 1460,
1375, 1260, 1150, 1100, 1040,
840 cm 1
NMR Spectrum (CDC13, 90 MHz) ~: 1.50 & 1.53(each s,C(CH3)3),
2.30, 2.33(each s,COCH3), 3.61(d,J=lOHz,l/2 x CH of
diastereoisomer), 3.78(d,J=8Hz,l/2 x CH of diastereo
isomer), 4.16(dd,J=1.5 & 10Hz,l/2 4-H), 4.19(dd,J=
1.5 & ~Hz,l/2 4-H), 4.64 & 4.68(each d,J=1.5E3z,3-H),
6.97(br.s,NH)

1166~4~
- 32 -


Example 16
[3R,4R~-4-[1,3-Bis(t-butyloxycarbonyl)-3-diazo-2-oxopropyl]-3
bromo-2-oxoazetidine

.
A solution of 1.49 g (5 mMol) of methyl ~3S,4R]-2-(3-bromo-
4-chloro-2-oxoazetidin-1-yl)-2-isopropylidenylacetate in 100 ml
of dichloromethane is stirred at -78C. Ozone is allowed to pass
through the solution for 30 minutes until the complete consumption
of the starting material is observed by thin-layer chromatography.
Then, nitrogen gas is allowed to pass through the reaction mixture
for about 30 minutes to give a solution containing methyl [3S,
4R]-2-(3-bromo-4-chloro-2-oxoazetidin-1-yl)-2-oxoacetate. This
solution is cooled at -78C,to which is added dropwise a solution
of 1.36 g (5 mMol) of di-t-butyl ~-diazoacetone-dicarboxylate and
25 ml (5 mMol) of 0.2 N-sodium methylate in 10 ml of dichlorometh-
ane, followed by stirring for 20 minutes. To the reaction mixture
is added 2 ml of acetic acid, which is then concentrated under re-
duced pressure. The residue is shaken together with 150 ml of
ethyl acetate and 50 ml of water. The organic layer is washed
with a saturated aqueous solution of sodium chloride (3 x 50 ml),
dried over anhydrous magnesium sulfate, and concentrated under re-
duced pressure. The resulting product is subjected to silica-gel
chromatography (n-hexane:ethyl acetate 2:1-1:1). The fractions
containing the desired product are combined, and concentrated to
give 1.11 g of the titled compound as an oily substance. The
product is left standing at a refrigerator to cause partial crys-
tallization. Analytical data on the resulting crystals are as
follows: m.p. 136-138C


11~6640
- 33 -



Elemental analysis: C16H22BrN3O6
C(%) H(%) N(%)
Calcd.: 44.46 5.13 9.72
Found : 44.40 5.08 9.82
IR Spectrum ~max(~Br): 34ao, 3220, 3990, 2150(N2), 1765
1740, 1720, 1665, 1375, 1340,

1260, 1210, 1160, 1140, 1090 cm 1
NMR Spectrum (CDC13, 90 MHz) ~ : 1.45(s,C(CH3)3), 1.51(s.
C(CH3)3), 4.19(dd,J=2 & 5Hz,4-H), 4.63(d,J=5Hz,CH)
4.90 & 4.8a(each d,J=Hz,3-H), 6.28(br.s,NH)
[~]23+ 114 4 (c=0.825, CHC13)
Example 17
[3R,4R]-4-[1-t-~utoxycarbon~l-2-oxo-3-diazo-3-(2,2,2-tri-
chloroethoxycarbonyl)propyl]-3-phthalimido-2-oxoazetidine
A mixture consisting of 1.52 g of 2,2,2-trichloroethyl 2-
(2-t-butoxycarbonylacetyl)-2-diazoacetate, 2 ml of dichloromethane
a~d 20 ml of 0.2 M methanolic sodium methylate is stirred at
-70C. To the mixture is added at one portion 1.6 g of methyl
[3S,4R]-2-[4-chloro-3-phthalimido-2-oxoazetidin-1-yl)]-2-cxoacetate,
followed by immediate addition to the reaction mixture 10 drops of
acetic acid. The resulting mixture is concentrated under reduced
pressure. The oily residue is vigorously shaken together with
5 ml of ethyl acetate and 5 ml of a saturated aqueous solution of
sodium chloride. The organic layer is subjected to silica-gel
column chromatography (n-hexane-ethyl acetate=l:l). The fractions
containing the desired compound are combined, and concentrated to


- 34 -



give 2.4 g (yield: 85.4~) of the titled compound as a powder.

Elemental analysis: C22HlgC13N4O8.H2O

C(%) H(~) N(~)

Calcd.: 44.65 3.58 9.47

Eound : 44.42 3.64 8.91

IR Spectrum ~maX(Ksr): 3350, 2150, 1790, 1770, 1720,

1660, 1390, 1340, 1300, 1160,

720cm 1
NMR Spectrum (CDC13 , 90 MHz) ~: 1,34 & 1.47(each s,

C(CH3)3), 4.5-4~8 & 4.8-5.1(each m,4-H,CH2CC13 &

COCHCO), 5.25 & 5.32(each d.J=2.4Hz,3-H), 6.35 &

6.47(each br.s,NH),7.8-8.0(m,ar.H4)

[~]23 + 19 50(c=0.425, CHC13)

Example 18

[3R,4R]-4-(1-Ethylthiocarbonyl-l-p-nitrobenzyloxycarbonyl-


l_phendvlthio)methyl-3-phthalimido-2-oxoazetidine
, .
A solution of 363 mg of methyl [3S,4R]-2-(4-chloro-3-
phthalimido-2-oxoazetidin-1-yl)-2-isopropylidenylacetate in 50
ml of dichloromethane is stirred at -70C. Ozone is allowed to
pass through the solution (for about 15 minuted) until complete
consumption of the starting material is observed by means of
thin-layer chromatography. Nitrogen gas is allowed to pass through
the reaction mixture for about 30 minutes to give a solution con-
taining methyl [3S, 4R]-2-(4-chloro-3-phthalimido-2-oxoazetidin-
l-yl)-2-oxoacetate. This solution is stirred at -70C, to which
are added dropwise 2 ml of methanol and a mixture consisting of
210 mg of p-nitrobenzyl 2-ethylthiocarbonyl-2-phenylthioacetate,




. :.

64~
- 35 -



2 ml of dichloromethane and 3 ml of 0.2 M methanclic sodium methyl-
ate. To the reaction mixture are added, after stirring for 20
minutes, 0.5 ml of 2 _-HCl and 3 ml of methanol. The mixture is
washed with ice-water, then with a saturated aqueous solution of
sodium chloride, followed by concentration under reduced pressure.
The oily residue is subjected to silica-gel column chromatography
(n-hexane-ethyl acetate=l:l). The ~ractions containing the de-
sired product are combined and concentrated to afford 69 mg of
the titled compound as a powder.

IR Spectrum ~ax(KBr): 3415, 1798, 1721, 1524 cm 1
NMR Spectrum (CDC13, 60 MHz) ~ : 1.27(t,J=7Hz,CH2CH3~,
2.97 & 3.00(each q,J=7Hz,CH2CH3), 4.74 ~ 4.85(each
d,J=2.5Hz,4-H), 4.98(ABq,J=13 & 18Hz,-OCH2), 5.80
6.00(each d,J=2.5Hz,3-H), 6.63 & 6.70(each br.s,NH),
7.16-8.24(m,13H,ar.)
Example 19
[3R,4R]-4-[1,3-Bis(t-butyloxycarbonyl)-3-diazo-2-oxopropyl]-
3-phthalimido-2-oxoazetidine
A solution of 725 mg of methyl [3S,4R]-2-(4-chloro-3-
phthalimido-2-oxoazetidin-1-y)-2-isopropylidenylacetate in 100
ml of dichloromethane is stirred at -78C. Ozone is allowed to
pass through the solution (for about 30 minutes) until complete
consumption of the starting material is observed by means of
thin-layer chromatography. Nitrogen gas is then allowed to pass
through the reaction mixture for 30 minutes to give a solution
containing methyl [3S,4R]-2-(4-chloro-3-phthalimido-2-oxo-
azetidin-l-y)-2-oxoacetate. This solution is stirred at -78C,

116~6~
- 36 -



to which is added dropwise a solution consisting of 545 mg of di-
t-butyl 2-diazoacetonedicarboxylate, 10 ml of 0.2 N methanolic
sodium methylate and 10 ml of methanol. To the reaction mixture,
after stirring for 20 minutes, is added 1 ml of acetic acid, fol-
lowed by concentration under reduced pressure. The oily residue
is dissolved in 100 ml of ethyl acetate, and the solution is wash-
ed with 50 ml of water, then with a saturated aqueous solution of
sodium chloride (20 mlx3), followed by concentration under reduced
pressure. The oily residue is subjected to silica-gel column
chromatography (n-hexane-ethyl acetate=l:l). The fractions con-
taining the desired compound are combined and concentrated to dry-
ness to afford 400 mg (yield 41~) of the titled compound as an
oily substance.
Elemental analysis: C24H26N4O7.2H2O
C(%) H(%) N(%)
Calcd.: 55.59 5.83 10.81
Found : 55.75 5.36 10.02
IR Spectrum ymax(KBr): 3400, 2990, 2140, 1790, 1770

1720, 1645, 1400, 1370cm -1
NMR Spectrum (CDC13, 100 MHz)~ : 1.48 & 1.56(each s,2x
C(CH3)3), 4.48 & 4.56(each d,J=2Hz,4-H), 4.68(s,
enol OH), 5.28 & 5.34(each d,J=2Hz,3-H), 6.16 & 6.36
(each br.s,NH), 7.6-8.0(m,ar.H4)

.. 1l6664Q
- 36a

Example 20
[3S ! 4S]-4-(l-Acetyl-l-methoxycarbonyl)methyl-3-phthalimid
2-oxoazetidine
-
To the solution of 10 ml of 0.2 M methanolic sodium
methoxide cooled at -78C, are added dropwise with stirring
696 mg (6 mMol) of methyl acetoacetate and 672 mg (2 mMol)
of methyl [3R,4S]-2-(4-chloro-3-phthalimido-2-oxoazetidin-
1-yl)-2-oxoacetate in 4.6 ml of dichloromethane. After
3 min, 10 drops of acetic acid are added. The solutlon is
evaporated under reduced pressure and the residue is taken
into ethyl acetate, washed with water and dried over
anhydrous magnesium sulfate. The solution is evaporated to
dryness, the resulting residual solids are triturated with ethyl
ether and collected with suction to afford 441 mg (Y=54~) of
the titled compound, m.p. 158-159C (dec.).
IR Spectrum ~max(KBr): 3325, 1795, 1765, 1740, 1710
1400, 1300, 730 cm 1
NMR Spectrum (CDC13, 90 MHz) ~: 2.23 & 2.27(each s,
COCH3 doublet is due to enolization), 3.58 & 3.70
(each s,OCH3), 4.33(s, 4-H & OH), 5.23(s,3-H), 7.95
(s,aromatic), 8.72(s,NH)
Example 21-26
In place of methyl acetoacetate in Example 20, 6 mMol of
each of aarbon acids represented by the formula CH~ ~, wherein
R2, R3 and R4 are respectively defined in the following table,
is employed and the procedure of Example 5 is repeated to give
the corresponding [3S,4S~-3-phthalimido-4-substituted-2-

640
- 36b -

oxoazetidines as shown in the following table involving their
physico-chemical constants as well.
C \R I I U 1 ~1

NE ~__ O Spectrum NMR Spectrum (vent)~

R2R3 R4

21 Ht-C H OCO~ ClCH CO- (KBr):3330 (CDC13,9OMHz): +70.9
4 9 2 2990,2950, 1.43(S~(cH313c)r (0.485,
1720,1390 -COCHCO-), 4.30 CHC13)
(s,ClCH2)~ 4-63
(dd,J=3 & 9.6Hz,
4-H), 5.25(d,
J=3Hz,3-H), 6.58
(br.s,NH), 7.85
. _ _ _ ~ (m,aromatic) .




,~
. . ,

116664~
n ~ \ R4 ~ N~ 9p ~=trwl ~ ~D
Ex. ~ NH Spectrum ~ te,sol-
5 N IV aXem~l vent)
R2 R3 R4
. ~ ~
2 H ClCH2CO- 2 5 (KBr)~:3g?5 1.07 61.22(eaeh +(16il5,
1785, 1770, t,CH3CH2), 4.07 dioxane)
1760, 1740, & ~1r8(each t,
10 - 1715, 1390, J=7~2Hz~cH3cH2
1185, 720 4.35-4.65(m
. . . & -COC~CO-)
: , : , ~, -4.67-(s,GlCH2),
5.30(m,3-H),
7.95(s,aroma-
tie), 8.72 &
~ 8.78(eaeh s,NH)
_ . . . -I
2 H C~3CO- t-C4HgOCO~ (KBr):3250, 1.42 &i.48(eaah (04.91,
1720, 1470, s,~CH3)3C),2.33 CHC13)
. 1400, }375, (s,CH3CO), 3.73
1140, 720 & 3.78(eaeh d,
J=9.6Hz,-COC,HCO
4.52 &4.57(eaeh
d~,J~3 C 9.6Hz,
4-H), 5.08 &
5.20(eaeh d,J-
3Hz,3-H), 6.6
(br.s,NH),7.82
(m,aromatic)
~
2~ C~S ¦O2N ~ _CH20CO_ O2N ~ -CH20CO- (KBr):3270, (CDC13 90MHz)
1720, 1525, 4-H),4.93 &5.10
1400, 1350 (ABq,J-12.6Hz,
1260 CK2-C6H4-NO2)~
5.33(s,CH2-C~H4-
l NO2), 6.67(s,~
. NH), 6.9-8.25
(m,aromatic)
,, _ .


, .

~s-~e~o
- 38 -




C / R3 ~IR



Spectrum NMR Spectrum D
R R3 R Vmax vent)

Ht-C4HgOCO~ C13CCH2OCO tKBr):33s0, (CDC13,90MHz). -19.5
1780, 1720, (CH3)3C),4.5-4.8 CHC13)

1335, 1300, (m,-COCHCO-),4.90
1150, 720 &4.95(each s,

CH2CC13)'5 3 &
5.35teach d,J=
2.4Hz,3-H),6.50
&6.60(each
br.s,NH),7.8-
8.0(m,aromatic)
26 H CH3CO- CH3CO- (Nujol): (CDC13,60MHz): -42.5
1730, 1710, CH3),3 23-3 40(m, DMSo)75'

660 -COCHCO),4.40(d,
J=2Hz,4-H),5.15(d,
J=2Hz,3-H),7.75(s,

_ (s,NH) ,
Example 27
[3S,4S]-4-[1-t-Butoxycarbonyl-3-diazo-2-oxo-3-(2,2,2-trichloro-
ethoxycarbonyl)propyl]-3-(l-hydroxyisopropyl)-2-oxoazetidine

To 50 ml of 0.2 M methanolic sodium methoxide solution stirred
and cooled at -78C, are successively added 3.43 g of 2,2,2-tri-
chloroethyl 4-t-butyloxycarbonyl-2-diazo-3-oxobutyrate in 30 ml
of dichloromethane and 10 mMol equivalent of pivaloyloxymethyl
[3R,4S]-2-[4-chloro-3-(1-hydroxyisopropyl-2-oxoazetidin-1-yl]-
2-oxoacetate, which is prepared according to the procedure of




.,,

t~66~40
- 39 -

Example 1, in 30 ml of dichloromethane. After a few minutes,
0.6 ml of acetic acid is added to the solution and the solution
is evaporated to dryness under reduced pressure. The residue is
taken into 50 ml of ethyl acetate, washed with water, and dried
over anhydrous magnesium sulfate, followed by concentration under
reduced pressure to give the crude product. The product is sub-
jected to silica-gel column chromatography by use of n-hexane-
ethyl acetate = 1:2 for elution. The fractions containing the
desired compound are combined and concentrated to give 2.6 g of
the titled compound.
IR Spectrum Vmax(neat): 3350(br.), 2980,2150, 1740(br-),
1660, 1375, 1150, 1050 cm 1
22-5= -13 0 (c=0.795l CHC13)
Example 28
[3R,4R]-4-(1-Benzhydryloxycarbonyl-3-diazo-4-methoxy-
carbonyl-2-oxopropyl)-3-phthalimido-2-oxoazetidine
To 10 ml of 0.2 M methanolic sodium methoxide solution stirred
and cooled at -70C, are successively added 704 mg of methyl 4-
benzhydryloxycarbonyl-2-diazo-3-oxobutyrate in 1 ml of dichloro-
methane and 672 mg of methyl [3S,4R]-2-(4-chloro-3-phthalimido-2-
oxoazetidin-l-yl)-2-oxoacetate in 1 ml of dichloromethane. After
a few minutes, 3 drops of acetic acid is added to the solution
and the solution is evaporated to dryness under reduced pressure.
The residue is taken into 10 ml of ethyl acetate, washed with
water and dried over anhydrous magnesium sulfate. The solution is
concentrated under reduced pressure and the concentrate is sub-
jected to silica-gel column-chromatography (n-hexane-ethyl acetate=

11~6~
- 39a -

1:1). The fractions containing the desired compound are combined
and concentrated under reduced pressure to give 400 mg of the
titled compound.
IR Spectrum ~max(KBr): 3350, 2960, 2150, 1790, 1770,
1720, 1650, 1390, 1210, 720,
700 cm 1
NMR Spectrum (CDC13, 90 MHz) ~: 3.90(s,CH3), 4.4-5.4
(m,3-H,4-H and -COCHCO-), 6.33 & 6.47(each, br.s.NH),
6.8-7.2(m,CH(Ph)2), 7.37(s,aromatic), 7.7-8.0(m,
aromatic)
[~]D2 = +20.0 (c=0.3, CHC13)

- 40 -
Example 29-30
In place of methyl 4-benzhydryloxycarbonyl-2-diazo-
3-oxobutyrate in Example 28, 2 mMol each of carbon acids
having formula-, C~ R3, wherein R , R3 and R ar~ respec-
tively defined in t~e following table, is employed and theprocedure of Example 28 are repeated to give the
corresponding 13R,4R]-4-substituted-3-phthalimido-2-oxo-
azetidines as shown in the following table involving their
physico-chemical constants as well.


\ 1 IR r NW Speotrum 1 ~D
Ex. NH R Spectrum ~ (c,sol-
15 No _ I max vent)
R R3 ~
_ . ._ _. .
29 H t- O O (KBr):3350, (CDC13,60WHz):1.4- +19.1
4 9 CH OC-C-C 2975, 2150, 1.7~m,(CH3)3C), (0.4~h
3 " ~ 1790, 1720, 3.73, 3.83 &3.97 CHC13)
N2 1650, 1400, (each s,CH3)~, 4.72
1140, 800, (q,J=2 &9Hz,4-H),
720 4.87(d,J=9Hz,
-COCHCO-), 9.3-5.5
(m,3-H), 6.~7 &
6.90(each br.s,NH)
7.90(s,aromatic)
. _
25 30 H t- O O (KBr):3350, (CDC13,60MHz):1.3- +26.6
C4HgOCO~ CH30 ~ CHi20CCC- 2970 2150 3 90(s,0CH3), 4.60 (CHC315;
N2 1650, 1520, (q~J=2~4 & 8Hz, 3
1385, 1340, 4-H), 4.87(d,J=8Hz
1300, 1250, -COCHCO-), $.33(s,
1215, 1255, -CH2-C6H4-), 5.45
1220, 1155, ~d~J=2~4Hz~3-H)~
725 6.45 6 6.62~each
br.s,N~), 7,00 &
7.45(each d,J=9Hz,
aromatic), 7.88(s,
aromatic)
. _


- 41 - 116~4~


Example 31
[3R,4R]-4-~(1-Acetyl l-ethoxycar~onyl)ethyl]-3-p-hthalimid
2-oxoazetidine
To 10 ml of 0.2 M methanolic sodium methoxide cooled at -78C,
are added dropwise a solution of 864 mg of ethyl 2-methylaceto-
acetate and 672 mg (2 mMol) of methyl [3S,4R]-2-(4-chloro-3-phthal-
imido-2-oxoazetidin-1-yl)-2-oxoacetate in 5 ml of dichloromethane.
After 3 min, 10 drops of acetic acid are added to the reaction
mixture. The solvent is evaporated and the residue is taken into
ethyl acetate, washed with water and dried over anhydrous magnesium
sulfate. The solution is evaporated to dryness, the residue is
subjected to silica-gel column chromatography (silica gel, 30 g)
and developed with n-hexane-ethyl acetate (1:2). The fractions
containing the desired compound are combined and concentrated, and
the residue is triturated with ether to afford 200 mg of the titled
compound.
m,p. 135-145C
IR ~maX(neat): 3330, 2980, 1780, 1720, 1395, 1260, 1110,
915. 720 cm~1
NMR Spectrum (CDC13, 90 MHz) ~: 1,18 & 1.28(each t,
J=14.4Hz,CH2CH3), 1.52 & 1.53(each s,CH3), 2.20(s,
COCH3), 4.18 & 4.27(each q,J=14.4Hz,CH2CH3), 4.53 &
4.57(d,J=3Hz,4-H), 5.25 & 5.30(d,J=3Hz,3-H), 6.25 &
6..62~each br.s.NH), 7.7-8.0(m.aromatic H4)




~.~

ll¢6~a
- 41a -



Example 32
[3R,4R~-3-Benzyloxycarbonylamino-4-(l,l-bisacetyl)methyl-
2-oxoazetidine
A solution of 28 g of methyl [3R,4R~-2-(3-benzyloxycarbonyl-
amino-4-chloro-2-oxoazetidin-1-yl)-2-isopropylidenylacetate in 200
ml of dichloromethane is stirred at -70C. Ozone is passed through
the solution until the complete consumption of the starting mater-
ial is observed by means of thin-layer chromatography, for which
about 2 hr is required. Nitrogen gas is passed through the re-
action solution for about 30 min to give a solution


4 ~

containing methyl [3R,4R]-2-(3-benzyloxycarbonylamino-4-chloro-~-oxoazetidin-1-
yl)-2-oxoacetate.
This solution is stirred at -70C, to which is added dropwise a
solution consisting of 35 g of acetylacetone, 4.23 g of sodium methylate and
215 ml of methanol. After 3 min, 30 ml of acetic acid is added to the solution.
The solvent is evaporated under reduced pressure and the residue is shaken with
200 ml of ethyl acetate and 200 ml of a saturated aqueous sodium chloride solu-
tion. The separated organic layer is dried over anhydrous sodium sulfate,
followed by concentration. The residual solids are recrystallized from ether-n-
hexane to give 9.8 g of the titled compound as a colorless needles. mp.
134-136C

IR Spectrum ~ nujol: 3350,3250, 1760, 1740, 1710,
max -1
1690 cm
NMR Spectrum (CDC13, 60 MHz) ~: 2.30 ~ 2.33 (each s, CH3), 3.1-3.3(1H,
broad, CH~ COO )~ 4.10~d,J=2Hz,4-H), 4.50(q,J=2 ~ 9Hz, 3-H), S.lO(s,OCH2),
7.30ts,aromatic H5), 7.50(d,J=9Hz,NH), 7.90~s,NH)


Example 33


[3R,4R]-3-Benzyloxycarbonylamino-4-(1-t-butoxycarbonyl_l_acetyl) methyl-2-
oxoazetidine
A solution of 2.8 mMol of methyl [3R,4R]-2-(3-benzyloxycarbonylamino-
20 4-chloro-2-oxoazetidin-1-yl)-2-oxoacetate in 10 ml of dichloromethane, which is
prepared by the procedure described in example 32, is stirred at -78C, thereto
is added a solution consisting of O.S ml of t-butyl acetoacetate and 2.8 ml of
M methanolic lithium methoxide. After the mixture is stirred for 30 min., 1 ml
of acetic acid is added to the reaction solution. The solution is shaken with
lS0 ml of ethyl acetate and 30 ml of a saturated aqueous solution of sodium




-42-

llGB~40

chloride. The separated organic layer is dried over magnesium sulfate, followed
by concentration. The residue is subjected to flash column chromatography
[silica gel, 30 g ~Art 92S5 Silica-gel 60, Mesh 230-400, Merck, Germany)] and
developed




-42a-

I 166640
- 43 -

with ethyl acetate-n-hexane (1:1) as eluent. The fractions con-
taining the desired compound are collected and evaporated to
afford 433 mg of the titled compound as colorless solid.
Thin Layer Chromatography: Rf=0.33 (Merck TLC plate 60 F25~,
AcOEt-n-hexane = 1:1)
IR Spectrum ~max(KBr): 3320, 2980, 1770, 1710, 1530,
1455, 1370, 1260, 1145, 1055
840, 780, 740, 700 cm 1
NMR Spectrum (CDC13, 60 MHz) ~: 1,38 & 1.40(each s,
C(CH3)3), 2.20(s,CH3CO), 3.67(d,J=9Hz,-COCHCO-),
3.5-4.5(m,4-H), 5.56(dd,J=2 & 8Hz,3-H, 6.29 & 6.25
(each d,J=8Hz,3-NH), 6.85(s,NH), 7.19(s.aromatic H5)

Representative Drawing

Sorry, the representative drawing for patent document number 1166640 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1984-05-01
(22) Filed 1981-11-12
(45) Issued 1984-05-01
Expired 2001-05-01

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1981-11-12
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
TAKEDA CHEMICAL INDUSTRIES, LTD.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-12-07 1 6
Claims 1993-12-07 11 236
Abstract 1993-12-07 1 19
Cover Page 1993-12-07 1 17
Description 1993-12-07 49 1,768